Tilray Inc (NASDAQ:TLRY)

77.20
Delayed Data
As of Jan 18
 -6.25 / -7.49%
Today’s Change
20.10
Today|||52-Week Range
300.00
+9.44%
Year-to-Date

Today’s Trading

Previous close83.45
Today’s open84.90
Day’s range75.00 - 86.43
Volume5,950,177
Average volume (3 months)5,461,361
Market cap$10.2B
Data as of 4:00pm ET, 01/18/2019

Growth & Valuation

Earnings growth (last year)+2.44%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+62.43%
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NBIXNeurocrine Bioscienc...+2.93+3.31%
EXASExact Sciences Corp+3.17+4.19%
BLUEbluebird bio Inc+3.46+2.74%
NKTRNektar Therapeutics+0.78+1.72%
Data as of 4:00pm ET, 01/18/2019

Financials

Next reporting dateFebruary 27, 2019
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$20.5M
Annual profit (last year)-$7.8M
Net profit margin-38.02%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Brendan Kennedy
Chief Financial Officer, Secretary &
Treasurer
Mark Castaneda
Corporate headquarters
Nanaimo, British Columbia

Forecasts